ZA904915B - Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines - Google Patents

Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines

Info

Publication number
ZA904915B
ZA904915B ZA904915A ZA904915A ZA904915B ZA 904915 B ZA904915 B ZA 904915B ZA 904915 A ZA904915 A ZA 904915A ZA 904915 A ZA904915 A ZA 904915A ZA 904915 B ZA904915 B ZA 904915B
Authority
ZA
South Africa
Prior art keywords
gpiii
gpii
varicella
vaccines
zoster virus
Prior art date
Application number
ZA904915A
Other languages
English (en)
Inventor
Alex Bollen
Bollen Alex
Michel Heinderyckx
Heinderyckx Michel
Marc Massaer
Massaer Marc
Diane Gregoire
Gregoire Diane
Paul Jacobs
Jacobs Paul
Original Assignee
Smithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biolog filed Critical Smithkline Biolog
Publication of ZA904915B publication Critical patent/ZA904915B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrically Driven Valve-Operating Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Liquid Crystal (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA904915A 1989-06-27 1990-06-25 Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines ZA904915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37177289A 1989-06-27 1989-06-27

Publications (1)

Publication Number Publication Date
ZA904915B true ZA904915B (en) 1991-06-26

Family

ID=23465352

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904915A ZA904915B (en) 1989-06-27 1990-06-25 Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines

Country Status (15)

Country Link
EP (1) EP0405867B1 (xx)
JP (1) JPH0349694A (xx)
KR (1) KR0166585B1 (xx)
AT (1) ATE119939T1 (xx)
AU (1) AU625328B2 (xx)
CA (1) CA2019845A1 (xx)
CY (1) CY1933A (xx)
DE (1) DE69017769T2 (xx)
DK (1) DK0405867T3 (xx)
ES (1) ES2071770T3 (xx)
HK (1) HK1006468A1 (xx)
IE (1) IE66516B1 (xx)
NZ (1) NZ234222A (xx)
PT (1) PT94479B (xx)
ZA (1) ZA904915B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196163T1 (de) 1990-10-04 2000-09-15 Res Corp Technologies Inc Varicella-zoster virusantigen
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
DK0651789T4 (da) 1992-07-17 2009-07-27 Merck & Co Inc Fremgangsmåde til at forebygge zoster eller lindre varicella-forbundet post-herpetisk neuralgia
GB9226768D0 (en) * 1992-12-23 1993-02-17 Smithkline Beecham Biolog Vaccines
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
KR970006484A (ko) * 1995-07-27 1997-02-21 수두 바이러스의 당단백질을 대량발현시키는 동물세포주
ATE390146T1 (de) * 1996-02-09 2008-04-15 Smithkline Beecham Biolog Vakzine gegen das varicella zostervirus produkt von gen 63
US7112331B2 (en) 1996-02-09 2006-09-26 Smithkline Beecham Biologicals, S.A. Vaccines against varicella zoster virus gene 63 product
KR100434023B1 (ko) * 1996-02-29 2005-05-09 주식회사 엘지생명과학 수두바이러스의당단백질을대량발현시키는동물세포주
DE19757767A1 (de) 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
MX2019006728A (es) 2016-12-07 2019-12-02 Glaxosmithkline Biologicals Sa Nuevo proceso.
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
EP3615061A1 (en) 2017-04-28 2020-03-04 GlaxoSmithKline Biologicals S.A. Vaccination
BR112019025193A2 (pt) 2017-05-30 2020-06-23 Glaxosmithkline Biologicals S.A. Métodos de fabricação de um adjuvante lipossomal, de fabricação de um concentrado lipossomal, para a preparação de uma composição imunogênica com adjuvante e para a preparação de uma solução, adjuvante lipossomal, composição imunogênica com adjuvante, e, solução
MX2020005481A (es) 2017-12-01 2020-12-07 Glaxosmithkline Biologicals Sa Purificacion de saponina.
JP2021533162A (ja) 2018-08-07 2021-12-02 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム プロセス及びワクチン
WO2020109365A1 (en) 2018-11-29 2020-06-04 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
CN114080393A (zh) 2019-06-05 2022-02-22 葛兰素史克生物有限公司 皂苷纯化
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
CN112142829B (zh) * 2019-06-28 2022-02-22 怡道生物科技(苏州)有限公司 水痘-带状疱疹病毒gE蛋白突变体及其表达方法
CN115819616A (zh) * 2021-07-28 2023-03-21 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
EP4169513A1 (en) 2021-10-19 2023-04-26 GlaxoSmithKline Biologicals S.A. Adjuvant composition comprising sting agonists
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
ATE230798T1 (de) * 1984-04-06 2003-01-15 Chiron Corp Rekombinanter herpes simplex gb-gd-impfstoff
US4769239A (en) * 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
EP0211756A1 (en) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay for varicella-zoster virus (VZV) antibodies
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
KR890701745A (ko) * 1987-06-30 1989-12-21 원본미기재 O-결합 글리코실화가 감소된 바이러스 단백질

Also Published As

Publication number Publication date
PT94479B (pt) 1997-05-28
CA2019845A1 (en) 1990-12-27
ATE119939T1 (de) 1995-04-15
IE66516B1 (en) 1996-01-10
PT94479A (pt) 1991-02-08
AU625328B2 (en) 1992-07-09
IE902297L (en) 1990-12-27
KR910001060A (ko) 1991-01-30
DE69017769D1 (de) 1995-04-20
EP0405867A1 (en) 1991-01-02
IE902297A1 (en) 1991-01-16
JPH0349694A (ja) 1991-03-04
KR0166585B1 (ko) 1999-01-15
DK0405867T3 (da) 1995-05-22
EP0405867B1 (en) 1995-03-15
DE69017769T2 (de) 1995-07-13
AU5779290A (en) 1991-01-03
NZ234222A (en) 1992-03-26
ES2071770T3 (es) 1995-07-01
CY1933A (en) 1990-06-22
HK1006468A1 (en) 1999-02-26

Similar Documents

Publication Publication Date Title
ZA904915B (en) Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
AU4325089A (en) Viral vaccines
IL80895A0 (en) Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
GB2264949B (en) Measles virus recombinant poxvirus vaccine
DE69016245D1 (de) Artikel zur Gewebekonditionierung.
EP0453497A4 (en) Treatment methods and vaccines
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
NZ234932A (en) Pseudorabies virus containing a mutation in the protein kinase region and/or the 28k region, and a vaccine containing it
AU5836390A (en) Human lymphoma-associated virus
ZA908189B (en) Infectious bronchitis virus vaccine
DE69428610D1 (de) Methoden zur kultivierung von infektiösem laryngotracheitis virus und von "egg-drop-syndrome" verursachendem virus
NZ224862A (en) Taenia ovis antigens and vaccines
ZA905296B (en) Use of bluetongue virus proteins as vaccines components
HU9203976D0 (en) Vaccine based on modified herpes virus
IL96647A0 (en) Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
GB9016433D0 (en) Avipox virus promoters
ZA919198B (en) Measles virus recombinant poxvirus vaccine
AU6051396A (en) Measles virus recombinant poxvirus vaccine
ATA256890A (de) Vorrichtung zur aufbereitung, insbesondere geruchlosmachung, von gülle
FR2648712B1 (fr) Vaccin contre le virus de la leucemie bovine
ZA902894B (en) Herpesvirus recombinant poxvirus vaccine
GB9020799D0 (en) Viral vaccines
EP0043847A4 (en) HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.
ZA903475B (en) Novel proteins and the preparation thereof